Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
53.42
+2.11 (4.11%)
At close: Aug 22, 2025, 4:00 PM
53.20
-0.22 (-0.41%)
After-hours: Aug 22, 2025, 4:23 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $590.81 million as of August 22, 2025.
Market Cap
590.81M
Enterprise Value
534.89M
1-Year Change
n/a
Ranking
Category
Stock Price
$53.42
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $590.81M, an increase of 310.37%. That is a compound annual growth rate of 698.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 567.47M | 321.42% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 643.67B |
| Johnson & Johnson | 428.56B |
| AbbVie | 367.55B |
| UnitedHealth Group | 277.91B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 229.86B |